Chronic hepatitis C is a disease that can leave serious sequelae on the liver such as cirrhosis or liver cancer if not treated promptly. Therefore, patients need to use antiviral drugs to support the body and help the liver recover. Among them is a product that combines 2 antiviral drugs, Epclusa. So what does Epclusa do?

Glecaprevir-Pibrentasvir is a combination of 2 active ingredients used to treat chronic hepatitis C. This is a very dangerous viral infection of the liver that, if not treated early, can lead to complications of cirrhosis, liver failure or liver cancer.

Barivir is an antiviral drug used in the treatment of certain hepatitis conditions, which works by stopping or reducing the amount of the virus that causes hepatitis in the body to help the liver recover. However, patients only use the drug when prescribed by a specialist to ensure safety for health.

Mydekla 60 contains the main ingredient Daclatasvir (as Daclatasvir dihydrochloride) 60mg. The drug has been proven effective in preventing the development of the hepatitis C virus. For the drug to be effective, patients need to clearly understand the dosage and how to use it. Read the article below for more useful information about this drug.